TAOX
TAO Synergies Inc.NASDAQHealthcare$5.94+4.21%ClosedMarket Cap: $19.5M
As of 2026-04-07
Valuation
P/E (TTM)
—
PEG
—
P/B
0.50
P/S
65.27
EV/EBITDA
-1.55
DCF Value
—
FCF Yield
-32.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
100.0%
Operating Margin
-3025.2%
Net Margin
-9609.2%
ROE
-182.5%
ROA
-111.2%
ROIC
-37.7%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2025 | $203.4K | 100.0% | $-1.8M | $-3.9M | $-1.56 | — |
| Q2 2025 | $4.0K | 100.0% | $-3.0M | $-17.5M | $-11.26 | — |
| Q1 2025 | $0.00 | NaN% | $-1.1M | $385.2K | $0.12 | — |
| Q4 2024 | $0.00 | NaN% | $-2.2M | $-5.5M | $-4.18 | — |
| FY 2024 | $0.00 | NaN% | $0.00 | $-12.8M | $0.00 | — |
| Q3 2024 | $0.00 | NaN% | $-1.4M | $-5.7M | $-4.58 | — |
| Q2 2024 | $0.00 | NaN% | $-1.6M | $-1.3M | $-1.18 | — |
| Q1 2024 | $0.00 | NaN% | $-1.7M | $-206.7K | $-0.41 | — |
| FY 2023 | $0.00 | NaN% | $0.00 | $-6.0M | $-29.56 | — |
| FY 2022 | $0.00 | NaN% | $0.00 | $-5.6M | $-20.25 | — |
| FY 2021 | $0.00 | NaN% | $0.00 | $-12.6M | $-62.75 | — |